SCHEMBL1012979

SCHEMBL1012979

CCCCCCCCCCCCC(C)(N)C(=O)OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 5/20 0.44
FDPS P14324 2/20 0.44
MAPT P10636 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
EPHX1 P07099 1/20 0.41
CES2 O00748 1/20 0.40
KDM4E B2RXH2 1/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
ACAT1 P24752 1/20 0.39
SOAT1 P35610 1/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
GGPS1 O95749 1/20 0.38
S1PR1 P21453 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15320823 1.00 SMPD1 (0.44) SMPD1FDPSMAPTMEN1KMT2A
SCHEMBL593839 1.00 SMPD1 (0.44) SMPD1FDPSMAPTMEN1KMT2A
SCHEMBL1012944 1.00 SMPD1 (0.44) SMPD1FDPSMAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL11833266 0.98 SMPD1 (0.43) SMPD1FDPSMAPTMEN1KMT2A
SCHEMBL17138101 0.92 FDPS (0.41) SMPD1FDPSMAPTMEN1KMT2A
SCHEMBL22854370 0.92 FDPS (0.41) SMPD1FDPSMAPTMEN1KMT2A
Glycine SCHEMBL28128784 0.92 SMPD1 (0.42) SMPD1FDPSMAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL29099886 0.90 FDPS (0.39) SMPD1FDPSMAPTMEN1KMT2A
Hydrochloric Acid SCHEMBL29099884 0.90 FDPS (0.39) SMPD1FDPSMAPTMEN1KMT2A
SCHEMBL11850855 0.90 FAAH (0.49) MAPTMEN1KMT2AATMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240026312-A1 PURIFICATION OF PROTEINS WITH CATIONIC SURFACTANT HORIZON THERAPEUTICS USA, INC. 2024-01-25 US claimed
CN-115725201-A Cleaning liquid and liquid set for ink jet recording apparatus 京瓷办公信息系统株式会社 2023-03-03 CN claimed
CN-108328639-B Preparation method of calcium carbonate bone-rod-shaped nanoparticles 杭州雄鹰精细化工有限公司 2020-04-28 CN claimed
CN-108358227-B Preparation method of calcium carbonate bone-rod-shaped nanoparticle assembly structure 宁波普莱斯帝金属制品有限公司 2020-03-13 CN claimed
CN-108455646-B Preparation method of calcium carbonate bone-rod-shaped nanoparticle composite material 宁波普莱斯帝金属制品有限公司 2020-03-13 CN claimed
US-20200056160-A1 PURIFICATION OF PROTEINS WITH CATIONIC SURFACTANT HORIZON THERAPEUTICS USA, INC. 2020-02-20 US claimed
US-20170166873-A1 PURIFICATION OF PROTEINS WITH CATIONIC SURFACTANT HORIZON THERAPEUTICS U.S. HOLDING LLC (SUCCESSOR IN INTEREST TO HORIZON THERAPEUTICS, LLC) 2017-06-15 US claimed
US-9534013-B2 Purification of proteins with cationic surfactant HORIZON PHARMA RHEUMATOLOGY LLC (US) 2017-01-03 US claimed
EP-2013225-B1 PURIFICATION OF PROTEINS WITH CATIONIC SURFACTANT CREALTA PHARMACEUTICALS LLC (US) 2014-12-17 EP claimed
US-20090317889-A1 Purification of Proteins With Cationic Surfactant HORIZON THERAPEUTICS USA, INC. 2009-12-24 US claimed
EP-2013225-A2 PURIFICATION OF PROTEINS WITH CATIONIC SURFACTANT Savient Pharmaceuticals, Inc. (US) 2009-01-14 EP claimed
WO-2008051178-A2 PURIFICATION OF PROTEINS WITH CATIONIC SURFACTANT SAVIENT PHARMACEUTICALS, INC. (US) 2008-05-02 WO claimed
US-12624227-B2 Manufacturing method for thermal insulating material RESONAC CORPORATION (JP) 2026-05-12 US disclosed
US-20250313029-A1 PHOTOSENSITIVE RESIN COMPOSITION, FLEXOGRAPHIC PRINTING RAW PLATE, AND MANUFACTURING METHOD OF FLEXOGRAPHIC PRINTING PLATE ASAHI KASEI KABUSHIKI KAISHA (JP) 2025-10-09 US disclosed
US-20250143296-A1 METHOD FOR INACTIVATING VIRUSES OR BACTERIA KAO CORPORATION (JP) 2025-05-08 US disclosed
US-20250143295-A1 VIRAL OR BACTERIAL INACTIVATION AGENT COMPOSITION KAO CORPORATION (JP) 2025-05-08 US disclosed
CN-1092512-C Cosmetic make-up compositions PROCTER & GAMBLE (US) 2002-10-16 CN disclosed
CN-1125392-A Cosmetic make-up compositions PROCTER & GAMBLE (US) 1996-06-26 CN disclosed
US-4897261-A ORGANIC SOLVENTS, OIL AND WATER SOLUBLE POLYMERS,MOISTURIZERS, HYDROPHILIC AND LIPOPHILIC COMPONENTS SHISEIDO COMPANY LTD. (JP) 1990-01-30 US disclosed
US-4169764-A ADSORPTION, ELUTION AJINOMOTO CO., INC. (JP) 1979-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624227-B2 Manufacturing method for thermal insulating material ATG13, SAMM50, ACR SMPD1 4371/4885FDPS 3685/4885MAPT 58/4885
US-20250143295-A1 VIRAL OR BACTERIAL INACTIVATION AGENT COMPOSITION POLL, POLI, POLB SMPD1 1263/4885FDPS 4506/4885MAPT 1805/4885
US-20250143296-A1 METHOD FOR INACTIVATING VIRUSES OR BACTERIA POLI, POLL, POLB SMPD1 614/4885FDPS 4572/4885MAPT 1790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.